Dermata Therapeutics Inc. (DRMAW)
undefined
undefined%
At close: undefined
0.00
-100.00%
After-hours Dec 31, 1969, 07:00 PM EST

Income Statement (Annual)

Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.
Year FY23 FY22 FY21 FY20 FY19
Revenue - - - - -
Cost of Revenue - - - 322.00 1.35K
Gross Profit - - - -322 -1.35K
Operating Income -8.04M -9.67M -7.86M -3.17M -4.47M
Interest Income 247.22K 63.57K 45.61 197.27 250.75
Pretax Income -7.79M -9.61M -7.90M -3.24M -4.72M
Net Income -7.79M -9.61M -7.95M -3.43M -4.97M
Selling & General & Admin 3.97M 4.02M 4.40M 1.57M 1.85M
Research & Development 4.07M 5.65M 3.46M 1.61M 2.62M
Other Expenses - - - - -
Operating Expenses 8.04M 9.67M 7.86M 3.17M 4.47M
Interest Expense - - 45.61K 197.27K 250.75K
Selling & Marketing Expenses - - - - -
Cost & Expenses 8.04M 9.67M 7.86M 3.17M 4.47M
Income Tax - -9.67K 45.61K 197.27K 250.75K
Shares Outstanding (Basic) 194.00K 690.67K 520.54K 520.54K 520.54K
Shares Outstanding (Diluted) 194.96K 690.67K 520.54K 520.54K 520.54K
EPS (Basic) -40.18 -13.92 -15.27 -6.6 -9.55
EPS (Diluted) -39.98 -13.92 -15.27 -6.6 -9.55
EBITDA 247.22K - -7.86M -3.17M -4.47M
Depreciation & Amortization 8.04M 9.67M 322.00 322.00 1.35K